Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2007
Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancerF Andre, R Nahta, R Conforti, et al.
Cancer Research|April 19, 2006
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancerAstrid Lièvre, Jean-Baptiste Bachet, Delphine Le Corre, et al.
JAMA Dermatology|October 27, 2015
Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With PembrolizumabCamille Hua, Lise Boussemart, Christine Mateus, et al.
The Oncologist|November 27, 2009
CXCR4 expression in early breast cancer and risk of distant recurrenceFabrice Andre, Weiya Xia, Rosa Conforti, et al.
International Journal of Cancer|January 6, 2010
Additional value of EGFR downstream signaling phosphoprotein expression to KRAS status for response to anti-EGFR antibodies in colorectal cancerGeraldine Perkins, Astrid Lièvre, Carole Ramacci, et al.
Science Translational Medicine|August 18, 2020
Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapyXueguang Lu, Lei Miao, Wenting Gao, et al.
Nature|August 1, 2014
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapiesLise Boussemart, Hélène Malka-Mahieu, Isabelle Girault, et al.
Cancer Research|January 31, 2016
Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF-CRAF HeterodimerizationLise Boussemart, Isabelle Girault, Hélène Malka-Mahieu, et al.
Science (New York, N.Y.)|September 16, 2017
Fabrication of fillable microparticles and other complex 3D microstructuresKevin J McHugh, Thanh D Nguyen, Allison R Linehan, et al.
Pageof 11